EBC samples from twenty treatment-naïve patients with pathologically confirmed lung cancer and twenty healthy subjects were profiled for miRNAs expression. Selected microRNAs were further validated, using quantitative-PCR, in an independent set of 10 subjects from both groups.
A total of 78 miRNAs were found to be significantly upregulated in the EBC of lung cancer patients compared to the control group. Six of these 78 miRNAs were shortlisted for validation. Of these, miR-31-3p, let7i, and miR-449c were significantly upregulated, exhibited good discriminatory power.
Differential expression of miRNAs secreted by lung cells could be quantitated in EBC samples, and could be used as a potential non-invasive tool for early diagnosis of lung cancer.
方法:对来自20名未治疗的肺癌患者和20名健康受试者的EBC样品的miRNAs表达进行分析。
结果:发现与对照组相比,肺癌患者的EBC中总共有78个miRNAs显著上调。
结论:肺细胞分泌的miRNAs的差异表达可以在EBC样本中定量,